Acute Promyelocytic Leukemia - 34 Studies Found
| Completed |
: Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL : Acute Promyelocytic Leukemia : 2007-08-21 : Drug: Tamibarotene For induction therapy, tamibarotene will be self-administered via tablets on an outpa |
| Recruiting |
: Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia :
|
| Terminated |
: ASCT for Relapsed APL After Molecular Remission :
: 2009-05-21 : Procedure: autologous hematopoietic cell transplantation A |
| Completed |
: Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia :
|
| Recruiting |
: Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia : Acute Promyelocytic Leukemia : 2010-10-20 :
|
| Recruiting |
: National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup :
: 2014-07-11 : Other: observational |
| Enrolling by invitation |
: A Study for Improving the Outcome of Childhood Acute Promyeloid Leukemia : Childhood Acute Promyelocytic Leukemia : 2014-02-08 :
|
| Recruiting |
: Acute Promyelocytic Leukemia (APL) Treated With ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin : Leukemia : 2011-08-02 :
|
| Recruiting |
: Cytarabine (Ara-C) in Children With Acute Promyelocytic Leukemia (APL) : Leukemia : 2010-08-18 : Drug: Ara-c Drug: ATRA 25mg/m2 day until complete remissio |
| Completed |
: Comparison of Two Treatments in Intermediate and High-risk Acute Promyelocytic Leukemia (APL) Patients to Assess Efficacy in 1st Hematological Complete Remission and Molecular Remission : Leukemia, Myelocytic, Acute : 2009-08-18 :
|